Cell Impact has in recent years described the market as cautious, characterised by delays. Today, Cell Impact reports a further delay.
Sales of machinery has in recent times been a complementary area of focus. The current delay relates to a substantial transaction concerning the sale of a large number of machines.
"Our unique forming technology formed the basis of this agreement, and we had strong and realistic expectations of completing the transaction in June. Unfortunately, delays arose in the customer's project, which materialised at a very late stage of the negotiations," says Daniel Vallin, CEO of Cell Impact.
As a result of this latest delay, Cell Impact's available cash is expected to be sufficient only until the end of June. The company and its board are currently working to identify a solution to the situation.
This information is inside information that Cell Impact AB is obliged to make public pursuant to the EU Market Abuse Regulation.